Caris Life Sciences Reports Third Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
Caris Life Sciences, Inc. , a leading, patient centric, next-generation AI TechBio company, today reported financial results for the quarter ended September 30, ...
New data reveals differences in gene activity in the brains of men and women. They start in the womb and evolved millions of ...
Researchers at Karolinska Institutet and Yale University have created a multidimensional, molecular map of how the mouse ...
19hon MSN
Veracyte raises 2025 revenue outlook to $510M while accelerating double-digit growth investments
Q3 2025 Management View Marc Stapley, CEO, highlighted "another outstanding quarter" with core testing business revenue up 18% year-over-year after adjusting for Envisia, supported by 26% volume ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results